TickerFactsScreenerDevelopers

SANGAMO THERAPEUTICS, INC (SGMO) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $19.39M2017: $36.57M2018: $84.45M2019: $102.43M2020: $118.19M2021: $110.70M2022: $111.30M2023: $176.23M2024: $57.80M2025: $39.55M$39.55M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$39.55M-31.6%
2024$57.80M-67.2%
2023$176.23M+58.3%
2022$111.30M+0.5%
2021$110.70M-6.3%
2020$118.19M+15.4%
2019$102.43M+21.3%
2018$84.45M+131.0%
2017$36.57M+88.6%
2016$19.39M—